Ying Zhuo

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections

Lixin Zhang, Kezhi Yan, Yu Zhang et al. · Proceedings of the National Academy of Sciences · 2007 · 250 citations · Full text

Immunotoxicology, Immunology, Antimicrobial Chemotherapy +18

Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition

Bin Shan, Tso‐Pang Yao, Hong T. Nguyen et al. · Journal of Biological Chemistry · 2008 · 169 citations · Full text

Emt Markers, Developmental Biology, Pathological Emt +15

Medium optimization for the production of avermectin B1a by Streptomyces avermitilis 14-12A using response surface methodology

Hong Gao, Mei Liu, Jin‐Tao Liu et al. · Bioresource Technology · 2009 · 157 citations

Biosynthesis, Engineering, Biotransformation +10

Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen

Yan Zhuang, Xiang Wang, Hong T. Nguyen et al. · Journal of Hematology & Oncology · 2013 · 134 citations · Full text